The Mathematician Versus the Malignancy
Elie Dolgin • May 7, 2014
Patients have long received cancer treatments at the maximum tolerated dose on a regular schedule. Could a more sophisticated approach save lives?
Elie Dolgin meets one mathematical biologist whose theories are now being tested in the clinic to see if they can improve the efficacy of today's anticancer arsenal.
Continue reading at Nature Medicine.
With organoids, assembloids and a growing bioengineering toolkit, scientists are pushing the limits of human brain models.
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.